APLS vs ENPH · rev $781.4M vs P/E 56, rev $1.47B
Apellis Pharmaceuticals Inc (APLS) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
APLS currently screens at market cap $2.29B. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the APLS and ENPH stock pages for the full models.
Not investment advice.